Eribulin

Basic Information

Item Value
DrugBank ID DB08871
Evidence Level L5 (Computational Prediction)
Number of Predicted Indications 100

Predicted Indications (TxGNN)

The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.

# Indication Source
1 autosomal recessive familial Mediterranean fever KG + DL
2 dermatofibrosarcoma protuberans KG + DL
3 pleural mesothelioma KG + DL
4 malignant peritoneal mesothelioma KG + DL
5 ovarian myxoid liposarcoma KG + DL
6 pleural adenomatoid tumor KG + DL
7 pleural biphasic mesothelioma KG + DL
8 fibroblastic neoplasm KG + DL
9 pleural epithelioid mesothelioma KG + DL
10 heart fibrosarcoma KG + DL
11 well differentiated papillary mesothelioma KG + DL
12 conventional fibrosarcoma KG + DL
13 pericardium cancer KG + DL
14 pleural sarcomatoid mesothelioma KG + DL
15 kidney fibrosarcoma KG + DL
16 lymphohistiocytoid mesothelioma KG + DL
17 low grade fibromyxoid sarcoma KG + DL
18 benign PEComa KG + DL
19 uterine corpus perivascular epithelioid cell tumor KG + DL
20 lymphangiomyoma KG + DL
21 situs inversus KG + DL
22 familial Mediterranean fever, autosomal dominant KG + DL
23 iminoglycinuria KG + DL
24 familial caudal dysgenesis KG + DL
25 Marfan syndrome KG + DL
26 heart position anomaly KG + DL
27 laterality defects, autosomal dominant KG + DL
28 neonatal Marfan syndrome KG + DL
29 cryptogenic organizing pneumonia KG + DL
30 tuberous sclerosis KG + DL
31 obsolete Marfan syndrome type 2 KG + DL
32 Loeys-Dietz syndrome KG + DL
33 familial Mediterranean fever KG + DL
34 diaphragmatic or abdominal wall malformation KG + DL
35 male infertility with teratozoospermia due to single gene mutation KG + DL
36 situs ambiguus KG + DL
37 cutis laxa - Marfanoid syndrome KG + DL
38 malformation syndrome with hamartosis KG + DL
39 lung PEComa KG + DL
40 heterotaxy, visceral, 1, X-linked KG + DL
41 visceral heterotaxy KG + DL
42 external auditory canal aplasia/hypoplasia KG + DL
43 liver fibrosarcoma KG + DL
44 paralytic facial malformation KG + DL
45 cutaneous leiomyosarcoma (disease) KG + DL
46 desquamative interstitial pneumonia KG + DL
47 lymphoid interstitial pneumonia KG + DL
48 EDICT syndrome KG + DL
49 digestive tract malformation KG + DL
50 facial cleft KG + DL

(Showing top 50 of 100 predictions)

Disclaimer

These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.


← Back to Drug Search


Copyright © 2026 藥提醒科技有限公司 (yao.care). 本報告僅供研究參考,不構成醫療建議。

This site uses Just the Docs, a documentation theme for Jekyll.